O utcome prediction models are an attempt to provide reliable information about a patient's chances of survival or recovery and to facilitate decisions about certain aspects of care. Primary intraparenchymal hemorrhage (IPH) accounts for approximately 15% of all strokes and has the highest mortality, with 25-30% of IPH patients dying within 3 months. Many statistical models predicting outcome after IPHs have been developed (1) but have included patients irrespective of do-not-attempt-resuscitation (DNAR) orders (2). Even though DNAR orders do not indicate the withholding of any treatment other than cardiopulmonary resuscitation, they are associated with a decreased willingness to treat (3) and with an increased risk of death after IPH (4, 5). Clinicians and investigators applying such prognostic models have acknowledged the risk of a self-fulfilling prophecy (6), which seriously threatens the validity of such models. In this study, we sought not to promote yet another IPH prognostic model but rather to demonstrate quantitatively how inclusion of DNAR patients in the derivation of a prognostic model leads to overly pessimistic pre-dictions of outcome for individual patients without DNAR orders.
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METHODS
Ethics Approval. Ethics approval was obtained from the University of Washington Human Subjects Review Committee.
Setting. The work was performed at University of Washington Harborview Medical Center in Seattle, WA. We reviewed records of 424 consecutive patients admitted to a single hospital for spontaneous (primary) IPH between May 2001 and September 2003, excluding patients whose IPH was not arterial or was secondary to a vascular malformation, neoplasm, or some other known source. Harborview Medical Center is a Joint Commissioncertified primary stroke center that serves as a tertiary referral center for patients with severe neurologic disease. Approximately 20% of all Seattle and surrounding King County residents with IPH are admitted to this hospital. The Human Subjects Review Committee reviewed and approved the study. 
Measurements and Main Results:
We retrospectively abstracted information from medical records of intraparenchymal hemorrhage patients admitted to a single hospital. Using multivariate logistic regression of presenting clinical characteristics, but not do-not-attempt-resuscitation status, we generated a prognostic score for favorable outcome (defined as moderate disability or better at discharge). We compared observed probability of favorable outcome with that predicted, stratified by do-not-attempt-resuscitation status. We then generated a modified prognostic score using only non-do-not-attempt-resuscitation patients. Records of 424 patients were reviewed: 44% had favorable outcome, 43% had a do-not-attempt-resuscitation or-der, and 38% died in hospital. The observed and predicted probability of favorable outcome agreed well with all patients taken together. The observed probability of favorable outcome was significantly higher than predicted in non-do-not-attempt-resuscitation patients and significantly lower in do-not-attempt-resuscitation patients. Results were similar when applying a previously published and validated prognostic score. Our modified prognostic score was no longer pessimistic in non-do-not-attempt-resuscitation patients but remained overly optimistic in do-not-attempt-resuscitation patients.
Conclusions: Although our prognostic model was well-calibrated when assessing all intraparenchymal hemorrhage patients, predictions were significantly pessimistic in patients without and optimistic in those with do-not-attempt-resuscitation orders. Such pessimism may drive decisions not to attempt resuscitation in patients in whom a favorable outcome may have been possible, thereby creating a self-fulfilling prophecy. To be most useful in clinical decision making, intraparenchymal hemorrhage prognostic models should be calibrated to large intraparenchymal hemorrhage cohorts in whom do-not-attempt-resuscitation orders were not used. DNAR Orders. At this hospital, cardiopulmonary resuscitation is performed by default on any patient whose heart stops suddenly, unless a physician signs an order not to attempt cardiopulmonary resuscitation, a socalled DNAR order. Such an order is entered on a special form that includes the justification for the DNAR order, such as the preference of the patient or healthcare surrogate, a futility judgment by the treating physicians, or both. A DNAR order is not meant to affect any treatment other than cardiopulmonary resuscitation. In this study, the presence or absence of a DNAR order was documented but not included in the development of the IPH prognostic model.
Variables for the Prognostic Model. The variables used for prognostic model development were abstracted retrospectively from medical records. Demographic data included age, gender, race, and prehospital functional status. Clinical data included initial blood pressure, heart rate and rhythm, temperature, Glasgow Coma Scale score, serum glucose level, and brain imaging characteristics. Based on initial imaging reports, hemorrhage location was classified as supratentorial or infratentorial, and the following findings were documented as present or not: mass effect, midline shift, intraventricular extension, hydrocephalus, and herniation. The medical chart was carefully reviewed for functional status at the time of discharge and then translated into the modified Rankin scale. A favorable outcome (FO) was defined as moderate disability or better at time of hospital discharge, corresponding to a modified Rankin scale score of Յ3.
Prognostic Score Development. Clinical characteristics described in the previous section were entered into a multivariate logistic regression model to identify characteristics that were independently and significantly (p Ͻ .05) associated with FO. The prognostic score for each patient was calculated as the linear sum of the ␤ coefficients derived from the logistic regression model and was based on each patient's values for the variables in the model. The predicted probability of FO is a mathematical manipulation of the prognostic score to confine the results to the range of 0.0 -1.0. Thus, each patient had an individualized prognostic score and a corresponding predicted probability of FO. We then divided the patient cohort into five groups of equal size (quintiles) based on their predicted probability of FO, with quintile 1 representing a low probability of FO (worst prognosis) and quintile 5 a high probability of FO (best prognosis). Finally, observed and predicted proportions of FO were stratified by DNAR status. The ratio of observed to predicted proportion of FO was used to define pessimism; if a higher proportion of patients was observed to have favorable outcome than had been predicted (O/P Ͼ1), then the model was considered pessimistic.
To support our findings, we used another validated prognostic model, the intracerebral hemorrhage (ICH) score (7), with each ICH score value as an indicator variable in a logistic regression to generate predicted probabilities of FO for each ICH score value, as we had performed for the prognostic score described. The score could be calculated only in the subset of our cohort in which all the needed data elements were available, or 300 of the 424 patients. As in the original report (7) , scores ranged from 0 to 5 and no one scored 6. Both non-DNAR and DNAR patients were included in the model that generated probability of FO. We then compared the observed and predicted proportions of FO by ICH score stratified by DNAR status. Details of the models are contained in Supplemental  Table I ( Formal statistical testing of goodness-of-fit of the prognostic models in all patients and in the non-DNAR and DNAR patients, separately, was performed using the Hosmer-Lemeshow goodness-of-fit (HL-GOF) test. This approach compares observed to predicted outcomes in groups divided by percentiles of predicted outcome using the chi-square test statistic. A nonsignificant p (Ͼ0.05) for this HL-GOF test indicates a model with good fit; a significant p value indicates important differences exist between the observed and predicted values and a model with a poor fit (8) . All analyses were performed using STATA (version 10; Stata-Corp, College Station, TX).
RESULTS
We identified 424 patients with a mean age of 65 yrs; 49% were women and 43% had a DNAR order (Table 1) . Overall, 38% died in hospital and 44% had FO at discharge. The DNAR order was written on the day of admission in approximately one-third (64 of 183; 35%), by hospital day 2 or 3 in another one-third (61 of 183; 33%), and on days 4 -6 (22 of 183; 12%) or thereafter (36 of 183, 20%) in the remaining one-third.
According to our multivariate logistic regression including all patients, irrespective of DNAR orders, factors significantly and independently associated with outcome were age, Glasgow Coma Scale score, heart rate, IPH mass effect, intraventricular extension, premorbid level of function, and systolic blood pressure (Table 1) . Even though significantly more DNAR patients were using anticoagulation at the time of admission than non-DNAR patients, after multivariate logistic regression warfarin use was not an independent predictor of outcome. Excluding patients who were using warfarin did not substantively change the results (data not shown). The overall performance of our prognostic score was excellent, and the area under the receiveroperator curve was 0.93 (an area under receiver-operator curve of 1.0 indicates perfect performance). When all patients were taken together, irrespective of DNAR orders (Fig. 1a ), observed and predicted proportion of FO agreed well, indicating a model with a good fit (HL-GOF, p ϭ .97). When accounting for DNAR status (Fig. 1b, c) , this agreement is lost, indicating models with a poor fit (both with HL-GOF, p Ͻ .001). Using the ICH score as an alternative prognostic score (7) to generate the probability of FO for both non-DNAR and DNAR patients yielded similar results. The predictions were pessimistic in the non-DNAR group and optimistic in the DNAR group (Fig. 2) (both HL-GOF, p Ͻ .001).
Finally, when including only non-DNAR patients to create another prognostic model, the independent prognostic factors were the same as for the entire cohort, except that age, ventricular extension, and heart rate were no longer significantly associated (Supplemental Table I , Supplemental Digital Content I, http://links.lww.com/CCM/A184). Predicted probabilities of FO were no longer pessimistic in the non-DNAR patients and the model had a good fit (HL-GOF, p ϭ .94), although they remained overly optimistic when applied to the DNAR group (Fig. 3 ).
DISCUSSION
To demonstrate quantitatively the pessimism intrinsic to IPH prognostic models, we created our own model that was derived from both non-DNAR and DNAR patients. Although our model was well-calibrated when assessing the entire cohort (Fig. 1a) , it overestimated the probability of FO for DNAR patients (Fig. 1b) while underestimating that for non-DNAR patients (Fig. 1c ). Using the validated ICH score (7) instead of our own prognostic scoring system led to a similar result (Fig. 2) . This pessimism in non-DNAR patients could be eliminated by developing the prognostic model using only non-DNAR patients (Fig. 3) .
Prognostication of patient outcome by relying on clinician experience and judgment represents the art of medicine. Prognostic models are an attempt to make this art a science. To create an objective prognostic model, important prognostic factors need to be identified and considered in the analyses. Most IPH prognostic models include patients with DNAR orders in the creation of the models without accounting for them in their analyses (2) . Only three published studies specifically examined the role of DNAR orders or withdrawal of life-sustaining measures in the prediction of outcome after IPH (5, 10, 11) . The few studies that accounted for any limitation of care in the development of an IPH outcome prediction model did this by excluding pa- score. This model was generated in 300 patients in whom the ICH score (1) could be calculated, irrespective of do-not-attemptresuscitation (DNAR) orders. Model performance is shown, stratified by DNAR status, and shows disparities between observed (white columns) and predicted (gray columns) probability of favorable outcome (FO) indicating models with poor fit (for both, goodness-of-fit p Ͻ .001). Numbers of patients for ICH scores 0 -4, respectively, are 58, 60, 32, 15, and 4 for non-DNAR patients (a) and 2, 18, 25, 58, and 24 for DNAR patients (b). Because only four patients had ICH score 5, all of whom had a poor outcome, these were not included in logistic model or figures. tients with particularly severe conditions (11) (12) (13) . It is just this group of patients, however, in whom the issue of prognostic pessimism is important. Our model tended to be particularly pessimistic for those patients with moderate to moderately severe IPH, represented by quintiles 2 and 3 in Figure 1 , and in whom a DNAR order has not been signed. This pessimism may drive the decision to assign a DNAR order to an individual in whom a favorable outcome may have been possible. The unintended result may be a selffulfilling prophecy (9, 14) , in which DNAR orders themselves lead to worse patient outcome and increased mortality. The findings from our models may be used to estimate the number of patients who would lose their chance of a favorable outcome because of IPH prognostic pessimism (Fig. 4) . The data for this figure are derived from a tertiary referral center, where a higher percentage may be expected of patients with moderate to moderately severe IPH and, within this group, of patients with DNAR orders. To illustrate the uncertainty around our estimate, we computed a 95% confidence interval on the observed risk difference. Still, at least 100,000 IPH patients worldwide and several thousand just in the United States might be denied aggressive care because of an overly pessimistic prediction of poor outcome.
Although our study has strengths in a large number of patients, such as assessment of functional outcomes rather than death and careful analyses with supplemental tables that enable the interested reader to follow the development of our prognostic model, it also has its weaknesses. The retrospective abstraction of information when the outcome is "function at hospital discharge" risks the reviewer's knowledge of the outcome affecting the classification of prognostic factors. The DNAR orders were easily identified but were not initiated in a standard fashion or at a standard time. Our analysis did not incorporate the reasons for why a DNAR order was written, and it is conceivable that some patients were given a DNAR order based on a medical complication developing later in their hospital course. To assess the possible impact of such a bias, we re-analyzed the data excluding patients with a late DNAR order, defined as one written at or after 72 hrs of hospitalization. Even with this new definition, favorable outcome was overestimated for DNAR patients and underestimated for non-DNAR patients, with the pessimism remaining statistically significant. We also did not know if patients had DNAR orders before their bleeds. Given the excellent premorbid functional status, regardless of subsequent DNAR status, few if any patients likely had DNAR orders before their bleeds.
We did not collect information on withdrawal of life-sustaining measures and so-called comfort care. We may have neglected to collect information on some other major prognostic factor or determinant of DNAR status, but our model contained variables similar to the many other prognostic models previously reported (1) . In comparison to patients who were not considered DNAR, DNAR patients were more likely to have medical comorbidities, a worse clinical status on admission, and a poor outcome (Supplemental Table I at Supplemental Digital Content I, http://links.lww.com/CCM/A184). The potential for unintended consequences of DNAR orders is well-known (3) (4) (5) . In other words, patients with a poor prognosis IPH are more likely to have a DNAR order, and patients with a DNAR order have a worse prognosis. However, this potential causal relationship does not lessen the main interpretation of our study, namely that the presence of DNAR patients in cohorts used for prognostic model derivation leads to pessimistic outcome predictions for those patients who are not considered DNAR. This model was developed from the experience of a single tertiary referral center and has not been externally validated. It should be emphasized that this model was developed solely for demonstration purposes and is not intended for clinical use. It should also be kept in mind that the ICH score was developed to assess 30-day mortality and, more recently, has been validated for the prediction of functional outcome at 1 yr (15), whereas our analyses assessed functional outcome prediction at discharge. Although the lack of long-term follow-up may weaken the clinical usefulness of our Figure 1 , i.e., moderate and moderately severe IPH. The 95% confidence interval for difference of 43% is 31% to 54%; therefore, 95% confidence intervals for the final estimates for worldwide (United States) are 102,449 -178,459 (5323-9273) (16, 17) . DNAR, do not attempt resuscitation. model, it does not change the observed effect of including DNAR patients in the derivation of prognostic models for IPH. Creating a prognostic model using data from non-DNAR patients only eliminated the problems introduced in models by ignoring DNAR status, but it also raises the question as to whether this non-DNAR subset is representative of all IPH patients.
CONCLUSIONS
To make an informed decision about their loved one's medical care, families ask what the most likely outcome will be. Implicit in this question is the assumption that this is the outcome that would be achieved if aggressive care were to be continued. To be most objective and useful in clinical decision making, IPH prognostic models should be calibrated to large IPH cohorts with the full spectrum of disease severity and in which patients are not considered DNAR and in whom aggressive care is reasonably pursued. Although the limitation of aggressive care is likely appropriate in individual cases of severe IPH, medical providers need to acknowledge and account not only for their own values and biases but also for those inherent in the prognostic models they use when communicating with families, interpreting patient's wishes, and helping them make a decision about life or death.
